Nkcfo LLC Horizon Therapeutics Public LTD CO Transaction History

Nkcfo LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 19, 2022	SELL	$58.92 - $84.67 $53,322 - $76,626	-905 Reduced 33.46%	1,800 $111,000
Q2 2022 Jul 08, 2022	BUY	$79.4 - $116.36 $142,920 - $209,448	1,800 Added 198.9%	2,705 $216,000
Q1 2022 Apr 28, 2022	BUY	$86.42 - $109.81 $22,901 - $29,099	265 Added 41.41%	905 $95,000
Q4 2021 Jan 27, 2022	BUY	$98.56 - $119.91 $63,078 - $76,742	640 New	640 $69,000
Q3 2021 Oct 21, 2021	SELL	$91.91 - $110.37 $202,202 - $242,814	-2,200 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$86.24 - $95.92 $189,728 - $211,024	2,200 New	2,200 $206,000
Q4 2020 Jan 28, 2021	SELL	$67.0 - $84.39 $311,550 - $392,413	-4,650 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$55.23 - $79.93 $256,819 - $371,674	-4,650 Reduced 50.0%	4,650 $361,000
Q2 2019 Jul 31, 2019	BUY	$22.81 - $28.48 $212,133 - $264,864	9,300 New	9,300 $224,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Nkcfo LLC, based on Form 13F filings with the SEC.

Stay updated on Nkcfo LLC with notifications on news.